Greenland Capital Management’s Avidity Biosciences RNAM Stock Holding History

Greenland Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,242	Closed	-$1.17M	–	387
2025 Q4	$1.17M	Buy	+16,242	New	+$1.05M	0.12%	171

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Greenland Capital Management's RNAM Position: Q1 2026 in Review

Greenland Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 16,242 shares — an estimated $1.17M sold.

Greenland Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.17M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Greenland Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Greenland Capital Management sold 16,242 Avidity Biosciences shares in Q1 2026, an estimated $1.17M.
Greenland Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Greenland Capital Management's Avidity Biosciences position peaked at $1.17M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Greenland Capital Management's 13F filing for Q1 2026, filed 15 May 2026.